>>> US Close Dow-0,42% S&P-0,29% Nasdaq -0,39%

Closing Market Summary: Market Begins August on Cautious Note

The stock market finished a down week on a cautious note with small caps leading the retreat. The Russell 2000 lost 0.5%, widening its weekly decline to 2.6%, while the S&P 500 shed 0.3%. The benchmark index ended the week lower by 2.7%.

This morning, the market was provided a basis to rebound with the July employment report, which was just right for the policy doves (209K versus consensus 220K). It showed payroll growth that was weaker than expected, average hourly earnings that were flat, and an uptick in the U6 unemployment rate (accounts for underemployed and unemployed workers) to 12.2% from 12.1%.

All of those factors speak in favor of the Federal Reserve not being in a rush to raise the fed funds rate, but the market did not rally on those cues. Instead, the S&P 500 made a brief morning appearance in the green before sliding into negative territory, where it spent the afternoon. The benchmark average was able to climb off its low into the close, but could not return into positive territory.

Three sectors registered gains, while the remaining seven finished lower. In general, countercyclical groups had a decent showing with consumer staples (+0.8%) and utilities (+0.4%) posting gains, while the telecom services sector (-0.9%) ended among the laggards. The largest countercyclical group—health care—settled flat.

Notably, the staples sector finished in the lead thanks to a boost from Procter & Gamble (PG 79.65, +2.33). The Dow component rallied 3.0% after reporting a bottom-line beat on revenue that was a bit below estimates.

Elsewhere, the health care sector received support from large components like Aetna (AET 78.73, +1.20), McKesson (MCK 195.43, +3.57), and WellPoint (WLP 111.00, +1.19). The three gained between 1.1% and 1.9%, while biotechnology lagged. The iShares Nasdaq Biotechnology ETF (IBB 250.28, -0.55) shed 0.2%.

For its part, the utilities sector staged a rebound after losing 6.9% last month.

On the cyclical side, the materials sector (+0.1%) was the lone advancer thanks to relative strength among miners. The Market Vectors Gold Miners ETF (GDX 26.20, +0.29) added 1.1%, while gold futures climbed 0.9% to $1294.60/ozt.

Meanwhile, the daylong weakness among influential sectors like energy (-0.7%), financials (-0.9%), and technology (-0.4%) prevented the market from turning positive. In the financial sector, JPMorgan Chase (JPM 56.48, -1.19) was the worst performer among the majors, falling 2.1%.

Lastly, the tech sector was pressured by top-weighted components like Google (GOOGL 573.60, -5.95), IBM (IBM 189.15, -2.52), and Microsoft (MSFT 42.86, -0.30). Chipmakers, however, held up relatively well. The PHLX Semiconductor Index added 0.4%.

Treasuries rallied through the first half of the session before holding near their highs during the afternoon. The 10-yr note advanced 17 ticks, sending its yield lower by six basis points to 2.50%.

Participation was above average for the second day in a row with nearly 780 million shares changing hands at the NYSE.

Economic data was plentiful with Nonfarm Payrolls, Personal Income/Spending data, Core PCE Prices, the final reading of the Michigan Sentiment survey, ISM Index, and the Construction Spending report:
Nonfarm payrolls added 209,000 jobs in July after adding an upwardly revised 298,000 (from 288,000) in June, while the consensus expected 220,000 new jobs in July
Private payrolls fared worse, adding only 198,000 jobs in July following a 270,000 increase in June
The consensus expected 225,000 new private jobs in July
Even more disappointing, hourly wages were flat after increasing 0.2% in June and the average workweek remained at 34.5 hours
The unemployment rate ticked up to 6.2% from 6.1%
Personal income increased 0.4% in June after rising by the same amount in May, which matched the consensus
Personal spending also matched estimates with a 0.4% increase in June, up from an upwardly revised 0.3% (from 0.2%) gain in May
The University of Michigan Consumer Sentiment Index increased to 81.8 in the final July reading from 81.3 in the preliminary reading, while the consensus expected an increase to 82.0
The Current Conditions Index was revised up to 97.4 from 97.1
The Expectations Index rose to 71.8 in the final reading from 71.1
The ISM Manufacturing Index increased to 57.1 in July from 55.3 in June, representing the strongest reading since April 2011
The consensus expected the index to increase to 55.9
Construction spending fell 1.8% in June after increasing an upwardly revised 0.8% (from 0.1%) in May, while the consensus expected an increase of 0.3%
Private construction fell 1.0% after increasing 0.4% in May
Residential construction declined 0.3% in June
There is no economic data scheduled to be released on Monday.

S&P 500 +4.2% YTD
Nasdaq Composite +4.2% YTD
Dow Jones Industrial Average -0.5% YTD
Russell 2000 -4.1% YTD

>>> LinkedIn: Color on qtr (180.64)

LinkedIn: Color on qtr (180.64)
  • Wunderlich Secuirities notes LinkedIn Corporation (LNKD) reported Q2 revenues, EBITDA, and EPS that were 3%, 14%, and 23% ahead of consensus, respectively. Guidance for next quarter was also ahead of the consensus and FY14 revenues and EBITDA guidance was raised by 8% and 4%, respectively. The company added 2,236 LinkedIn Corporate Solutions (LCS) customers, up from 1,400 last quarter and grew Talent revenues 57% Y/Y, ahead of estimates. Firm is raising estimates slightly with the expectation for continued beats and raises. Maintaining Buy rating and tgt of $250,
  • RBC Capital notes the Positives include: 1) Top Line Strength; 2) Solid Corporate Solutions Customer Adds; 3) increased penetration with existing clients, per management; 4) ARPU growth of 6% Y/Y was higher then expected; 5) EBITDA Margin Expansion... Negatives included 1) Soft Overall User & Engagement Growth.
  • FBR Capital notes LinkedIn (LNKD) growth improved after 10 quarters of deceleration. Guidance was also raised above consensus' estimates. Growth was led by Talent Solutions, while Marketing Solutions was the source of growth resurgence. The 3Q guidance implies deceleration to 39% growth at the high end. Among the wrinkles in the quarter was a 4.6% decline in FCF/share and lower engagement on tough comps. Raise tgt to $156 (from $141).
  • Topeka Capital notes LinkedIn delivered a nice upside quarter with revenues, Adj. EBITDA, and Adj. EPS handily above firm's estimates and consensus, and with guidance that was cleanly raised above consensus. Topeka continues to see an opportunity for more beat and raise quarters with guidance that could top Street expectations as LNKD executes. Longer-term sees LinkedIn benefiting financially from investments in R&D, Sales Solutions, Sponsored content, and China.
  • Needham Research notes LinkedIn's Q2 revenue and 2014 guidance exceeded expectations. The outperformance was driven primarily by ARPU acceleration and solid net new customer adds in Talent Solutions. Firm expects ARPU increases to be the main Talent Solutions revenue driver in 2H14. Marketing Solutions revenue growth remained solid, but is growing at a more modest pace than optimistic view. LinkedIn continues to be Needham's top large cap pick given its limited competition and innovative products that raise member and enterprise engagement, as well as drive incremental revenues.
LNKD is up approx 6% in pre-market trade; stock is testing its 200 sma.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance: WWWW -20.7% (also downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey), SREV -12%, MXWL -9.9%, ADNC -9.8%, CTRL -9.6%, GPRO -9.4%, YRCW -9.3% (light volume), BYD -9.1%, ARRS -7.8%, PXLW -7.2%, IMMR -6.6%, MT -6%, ABTL -4.4%, (light volume), MRC -3.8%, (light volume), SPWR -3.3%, AFFX -2.6%,OUTR -2.2%, PCYC -2.2%, OMG -2.1%, (light volume), RBS -1.9%, LYV -1.7%, GFIG -1.5% (light volume), KOG -0.9%, TSLA -0.6%, ASH -0.6%, WY -0.4%, (light volume).

Select financial related names showing weakness: DB -1.6%, UBS -1.3%, HSBC -1%, C -1% (to sell 80% of its $1.5 bln limited partnership interest in Metalmark Capital Partners II to Lexington ), CS -0.9%, BAC -0.7%, ING -0.6%.

Select metals/mining stocks trading lower: MT -5.9%, GOLD -2.5% (downgraded to Neutral from Buy at UBS), RIO -2.4%, BBL -1.4%, BHP -1.1%.

Select solar names lower following SPWR results: TSL -1.9% JKS -1.1% CSIQ -0.6%.

A few European drug names are trading lower: NVS -3.3%, GSK -1.6%, SHPG -1.1%, AZN -0.7%

Other news: BOTA -21.8% (reports top-line data From its Phase 2 IGLOO trial of Laninamivir Octanoate; neither the 40 mg or 80 mg cohort achieved a statistically significant reduction in the median time to alleviation of influenza symptoms), HIL -10.6% (priced public offering of common stock at $4.25/share after hours; intends to initially keep $10.0 mln of the net proceeds as cash or cash equivalents and to use the balance of the net proceeds from the offering), AIXG -7.3% (pulling back from two day gains), ALU -6.7% (continued weakness following earnings), SSYS -6% (announced that it has expanded European Ops ATHL -3.8% ( prices 12.5 mln share offering by selling shareholders at $46.25 per share ), PT -3.7% (continued weakness), RGSE -3.6% (filed for an offering of ~4.232 mln shares of Class A common stock by selling shareholders), VE -3.4% / SAP -1.9% (still checking), BONE -3.1% (announces public offering of common stock; size not disclosed), YY -2.4% (still checking), MSFT -1.5% (received unfavorable ruling yesterday in Ireland court ruling), RDS.A -1.4% (acknowledged outcome of Woodside Petroleum's shareholders' negative vote on selective buy-back proposal announced June 17 2014; Shell is reviewing its options in relation to its remaining 13.6% holding in Woodside), CDTI -1.3% (promotes David E. Shea to Chief Financial Officer), QIHU -1.3% ( priced private placement of $450 mln principal amount of convertible senior notes due 2020 and $450 mln principal amount of convertible senior notes due 2021), IGT -0.8% (following SGMS / BYI news).

Analyst comments: DDD -3.3% (downgraded to Sector Perform at RBC Capital Mkts; downgraded to Neutral from Overweight at Piper Jaffray, downgraded to Neutral from Buy at Citigroup), EHTH -1.4% (downgraded to Neutral from Buy at BofA/Merrill), BBBY -1.5% (downgraded at Opco).

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: ARNA +26.3%, IMPV +13.7%, AXTI +11.6%, GDOT +8.4%, TNDM +8.1%, SKUL +7%, SWIR +6.6%, LNKD +6.5%, BEAT +5.6%, (light volume), SYNA +5.2%, KCG +5.1%, EXPE +3.8%, IRE +3.7%, MHK +3.2%, AHS +3.1%, DATA +2.3%, WU +1.9%, (light volume), PG +1.8%, MCHP +1.3%, (light volume), CYH +1%, ONNN +0.9%, CTRX+0.9%, AVD +0.7%, (light volume), LNG +0.2%, (light volume), AIV +0.1%, (saw late move higher following early earnings release), .

M&A news: BYI +33.5% (Scientific Games to acquire Bally Technologies in transaction valued at $5.1 billion), IBCA +10.3% (Intervest Bancshares Corp to be acquired by Bank of the Ozarks in an all-stock transaction).

Select oil/gas related names showing strength: STO +0.8%, TOT +0.6%.

Other news: ARRY +8.5% (received orphan drug designation status for binimetinib for the treatment of ovarian cancer), SRPT +2.9% (announces appointment of John Hodgman as interim chairman; also initiated with an Outperform at Oppenheimer), JD +2.5% (trading higher following positive MadMoney mention), FNMA +1.4% (releases June 2014 monthly summary; Book of Business decreased at a compound annualized rate of 1.7% in June), VRTX +0.7% (light volume; receives European approval for KALYDECO (ivacaftor) in eight non-G551D gating mutations; KALYDECO is the first medicine to treat the underlying cause of CF in people with specific non-G551D gating mutations )

Analyst comments: RNA +3.9% (light volume, initiated with an Outperform at Oppenheimer), DV +0.3% (DeVry upgraded to Buy from Hold at Stifel)